[CLS] O
Models O
to O
predict O
intestinal O
absorption O
of O
therapeutic O
peptides O
and O
proteins O
. O
[SEP] O

[CLS] O
Antidepressant O
drugs O
are O
the O
preferred O
choice O
for O
treatment O
; O
however O
, O
treatment O
response O
is O
often O
variable O
. O
[SEP] O

[CLS] O
Similar O
trends O
were O
observed O
for O
remission O
although O
not O
statistically O
significant O
. O
[SEP] O

[CLS] O
Out O
of O
the O
117 O
individual O
persistent O
organic O
pollutants O
or O
metals O
assayed O
, O
46 O
could O
be O
detected O
in O
more O
than O
half O
of O
the O
placentas O
. O
[SEP] O

[CLS] O
The O
maternal O
body O
burden O
then O
was O
compared O
with O
its O
epidemiologically O
observed O
relationship O
with O
the O
IQ O
score O
. O
[SEP] O

[CLS] O
The O
order O
of O
concentration O
of O
the O
metals O
in O
the O
tissues O
is O
as O
follows O
: O
iron B
- O
blood O
> O
liver O
> O
testes O
; O
zinc B
- O
liver O
> O
blood O
> O
testes O
; O
lead O
- O
blood O
> O
liver O
> O
testes O
; O
copper B
- O
testes O
> O
liver O
> O
blood O
; O
nickel B
- O
liver O
> O
testes O
> O
blood O
. O
[SEP] O

[CLS] O
Volatile O
compound O
in O
cut O
and O
un O
- O
cut O
flowers O
of O
tetraploid O
Freesia O
hybrida O
. O
[SEP] O

[CLS] O
The O
studies O
also O
resulted O
in O
the O
identification O
of O
two O
known O
tetronic B
acids I
, O
viridicatic B
acid I
and O
terrestric B
acid I
, O
found O
in O
ethyl B
acetate I
and O
n B
- I
butanol I
extracts O
. O
[SEP] O

